ChromoGenics Future Growth
Future criteria checks 2/6
ChromoGenics is forecast to grow earnings and revenue by 44.5% and 39.2% per annum respectively while EPS is expected to grow by 82.6% per annum.
Key information
44.5%
Earnings growth rate
82.6%
EPS growth rate
| Building earnings growth | 10.4% |
| Revenue growth rate | 39.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 59 | -13 | N/A | -5 | 1 |
| 12/31/2025 | 45 | -20 | N/A | -11 | 1 |
| 12/31/2024 | 29 | -29 | N/A | -9 | 1 |
| 12/31/2023 | 16 | -53 | -41 | -41 | N/A |
| 9/30/2023 | 19 | -48 | -39 | -38 | N/A |
| 6/30/2023 | 23 | -49 | -51 | -50 | N/A |
| 3/31/2023 | 22 | -52 | -63 | -59 | N/A |
| 12/31/2022 | 24 | -57 | -64 | -59 | N/A |
| 9/30/2022 | 33 | -60 | -64 | -59 | N/A |
| 6/30/2022 | 36 | -56 | -70 | -59 | N/A |
| 3/31/2022 | 35 | -70 | -65 | -52 | N/A |
| 12/31/2021 | 29 | -64 | -75 | -59 | N/A |
| 9/30/2021 | 20 | -57 | -70 | -51 | N/A |
| 6/30/2021 | 15 | -65 | -64 | -47 | N/A |
| 3/31/2021 | 16 | -54 | -68 | -51 | N/A |
| 12/31/2020 | 20 | -62 | -70 | -50 | N/A |
| 9/30/2020 | 24 | -77 | -90 | -64 | N/A |
| 6/30/2020 | 34 | -82 | -139 | -113 | N/A |
| 3/31/2020 | 42 | -81 | -142 | -65 | N/A |
| 12/31/2019 | 46 | -78 | -131 | -62 | N/A |
| 9/30/2019 | 44 | -78 | -124 | -64 | N/A |
| 6/30/2019 | 30 | -70 | -78 | -19 | N/A |
| 3/31/2019 | 20 | -69 | -69 | -65 | N/A |
| 12/31/2018 | 11 | -73 | -69 | -63 | N/A |
| 9/30/2018 | 5 | -70 | -70 | -63 | N/A |
| 6/30/2018 | 9 | -71 | -63 | -58 | N/A |
| 3/31/2018 | 8 | -65 | -57 | -54 | N/A |
| 12/31/2017 | 7 | -57 | -57 | -55 | N/A |
| 9/30/2017 | 6 | -49 | N/A | -47 | N/A |
| 6/30/2017 | 4 | -46 | N/A | -46 | N/A |
| 3/31/2017 | 4 | -50 | N/A | -45 | N/A |
| 12/31/2016 | 3 | -49 | N/A | -40 | N/A |
| 9/30/2016 | 3 | -51 | N/A | -37 | N/A |
| 12/31/2015 | N/A | -44 | N/A | -43 | N/A |
| 12/31/2014 | N/A | -32 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CHRO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CHRO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CHRO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CHRO's revenue (39.2% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: CHRO's revenue (39.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CHRO's Return on Equity is forecast to be high in 3 years time